Clinical Trial Update: Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on using double dose magnesium sulfate for moderate-to-severe asthma in pediatric patients (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma in Children

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Oman Medical Speciality Board | Conditions: Asthma in Children | Phase 2, Phase 3 | Status: UNKNOWN